- Home
- HLI vs SNN Comparison
HLI vs SNN Comparison
Compare HLI & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLI
- SNN
- Stock Information
- Founded
- HLI 1972
- SNN 1856
- Country
- HLI United States
- SNN United Kingdom
- Employees
- HLI N/A
- SNN N/A
- Industry
- HLI Investment Managers
- SNN Industrial Specialties
- Sector
- HLI Finance
- SNN Health Care
- Exchange
- HLI Nasdaq
- SNN Nasdaq
- Market Cap
- HLI 14.4B
- SNN 13.2B
- IPO Year
- HLI 2015
- SNN 1999
- Fundamental
- Price
- HLI $193.98
- SNN $35.81
- Analyst Decision
- HLI Hold
- SNN Hold
- Analyst Count
- HLI 8
- SNN 3
- Target Price
- HLI $205.57
- SNN $31.50
- AVG Volume (30 Days)
- HLI 377.1K
- SNN 649.8K
- Earning Date
- HLI 10-29-2025
- SNN 10-30-2025
- Dividend Yield
- HLI 1.24%
- SNN 2.05%
- EPS Growth
- HLI 31.68
- SNN 59.91
- EPS
- HLI 5.94
- SNN 0.56
- Revenue
- HLI $2,480,866,000.00
- SNN $5,944,000,000.00
- Revenue This Year
- HLI $13.85
- SNN $7.75
- Revenue Next Year
- HLI $14.49
- SNN $5.37
- P/E Ratio
- HLI $32.68
- SNN $64.05
- Revenue Growth
- HLI 23.30
- SNN 5.35
- 52 Week Low
- HLI $137.99
- SNN $23.69
- 52 Week High
- HLI $211.78
- SNN $38.79
- Technical
- Relative Strength Index (RSI)
- HLI 35.93
- SNN 43.58
- Support Level
- HLI $199.58
- SNN $35.07
- Resistance Level
- HLI $205.36
- SNN $36.48
- Average True Range (ATR)
- HLI 4.42
- SNN 0.42
- MACD
- HLI -1.68
- SNN -0.13
- Stochastic Oscillator
- HLI 2.66
- SNN 34.62
About HLI Houlihan Lokey Inc.
Houlihan Lokey Inc is an investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, valuation, and strategic consulting. The firm serves corporations, institutions, and governments world-wide with offices in the United States, Europe, and the Asia-Pacific region. The company operates in three segments. In the Corporate Finance business segment, it provides M&A and capital markets advisory services. Through the Financial Restructuring business segment, the company advises on some of the complex restructurings around the world. The Financial and Valuation Advisory Services business segment provides valuation and financial opinion, and financial and strategic consulting practices in the United States.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.